The first was an EC diagnosed at 57 years from person ID_315-2 who carried the MSH2 c.1862G > T p.(Arg621Leu) variant, but the tumor showed loss of MLH1/PMS2+ expression related to tumor MLH1 promoter methylation. This evidence concerns the gene PMS2 and neoplasm.